Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0 cleartext transmission

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
5.1$0-$5k1.29

Summaryinfo

A vulnerability marked as problematic has been reported in Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0. The impacted element is an unknown function. This manipulation causes cleartext transmission. This vulnerability appears as CVE-2026-50034. The attack may be initiated remotely. There is no available exploit.

Detailsinfo

A vulnerability classified as problematic was found in Apollo Pharmacy Blood Glucose Monitoring System 0x0110_v1.1.0. Affected by this vulnerability is an unknown code. The manipulation with an unknown input leads to a cleartext transmission vulnerability. The CWE definition for the vulnerability is CWE-319. The product transmits sensitive or security-critical data in cleartext in a communication channel that can be sniffed by unauthorized actors. As an impact it is known to affect confidentiality. The summary by CVE is:

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

The weakness was presented by Rishitha Pucchakayala. The advisory is shared at apollopharmacy.in. This vulnerability is known as CVE-2026-50034 since 06/10/2026. The exploitation appears to be difficult. The attack can be launched remotely. The exploitation doesn't need any form of authentication. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1040 for this issue.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

Productinfo

Vendor

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔒
VulDB Reliability: 🔍

CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒

CVSSv3info

VulDB Meta Base Score: 5.1
VulDB Meta Temp Score: 5.1

VulDB Base Score: 3.7
VulDB Temp Score: 3.7
VulDB Vector: 🔒
VulDB Reliability: 🔍

CNA Base Score: 6.5
CNA Vector (icscert): 🔒

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍

Exploitinginfo

Class: Cleartext transmission
CWE: CWE-319 / CWE-310
CAPEC: 🔒
ATT&CK: 🔒

Physical: No
Local: No
Remote: Yes

Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔒

Timelineinfo

06/10/2026 CVE reserved
06/19/2026 +9 days Advisory disclosed
06/19/2026 +0 days VulDB entry created
06/19/2026 +0 days VulDB entry last update

Sourcesinfo

Advisory: apollopharmacy.in
Researcher: Rishitha Pucchakayala
Status: Not defined

CVE: CVE-2026-50034 (🔒)
GCVE (CVE): GCVE-0-2026-50034
GCVE (VulDB): GCVE-100-372313

Entryinfo

Created: 06/19/2026 07:57
Changes: 06/19/2026 07:57 (74)
Complete: 🔍
Cache ID: 216::103

Several companies clearly confirm that VulDB is the primary source for best vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Want to stay up to date on a daily basis?

Enable the mail alert feature now!